Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells - Concepedia

Concepedia

Publication | Open Access

Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells

DOI Full Paper Access

39

Citations

40

References

2016

Year

Seon‐Ok Lee, Joo-Seok Kim, Myoung-Sun Lee, Hyo‐Jeong Lee

Abstract

Taken together, these findings suggest that pristimerin can exert an anti-cancer activity by inhibiting HIF-1α through the SPHK-1 pathway.

References

	Year	Citations

Page 1